SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-003964
Filing Date
2024-01-08
Accepted
2024-01-08 08:30:42
Documents
71
Period of Report
2024-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d109855d8k.htm   iXBRL 8-K 27773
2 EX-99.1 d109855dex991.htm EX-99.1 23995
3 EX-99.2 d109855dex992.htm EX-99.2 52831
7 GRAPHIC g109855ex99_1p10g1.jpg GRAPHIC 393181
8 GRAPHIC g109855ex99_1p11g1.jpg GRAPHIC 433146
9 GRAPHIC g109855ex99_1p12g1.jpg GRAPHIC 255745
10 GRAPHIC g109855ex99_1p13g1.jpg GRAPHIC 306536
11 GRAPHIC g109855ex99_1p14g1.jpg GRAPHIC 308096
12 GRAPHIC g109855ex99_1p15g1.jpg GRAPHIC 271305
13 GRAPHIC g109855ex99_1p16g1.jpg GRAPHIC 354509
14 GRAPHIC g109855ex99_1p17g1.jpg GRAPHIC 318096
15 GRAPHIC g109855ex99_1p18g1.jpg GRAPHIC 269074
16 GRAPHIC g109855ex99_1p1g1.jpg GRAPHIC 169593
17 GRAPHIC g109855ex99_1p2g1.jpg GRAPHIC 475371
18 GRAPHIC g109855ex99_1p3g1.jpg GRAPHIC 321487
19 GRAPHIC g109855ex99_1p4g1.jpg GRAPHIC 378870
20 GRAPHIC g109855ex99_1p5g1.jpg GRAPHIC 193117
21 GRAPHIC g109855ex99_1p6g1.jpg GRAPHIC 314075
22 GRAPHIC g109855ex99_1p7g1.jpg GRAPHIC 247891
23 GRAPHIC g109855ex99_1p8g1.jpg GRAPHIC 370804
24 GRAPHIC g109855ex99_1p9g1.jpg GRAPHIC 328826
25 GRAPHIC g109855ex99_2p10g1.jpg GRAPHIC 341867
26 GRAPHIC g109855ex99_2p11g1.jpg GRAPHIC 312298
27 GRAPHIC g109855ex99_2p12g1.jpg GRAPHIC 241626
28 GRAPHIC g109855ex99_2p13g1.jpg GRAPHIC 364372
29 GRAPHIC g109855ex99_2p14g1.jpg GRAPHIC 274276
30 GRAPHIC g109855ex99_2p15g1.jpg GRAPHIC 247379
31 GRAPHIC g109855ex99_2p16g1.jpg GRAPHIC 215424
32 GRAPHIC g109855ex99_2p17g1.jpg GRAPHIC 307009
33 GRAPHIC g109855ex99_2p18g1.jpg GRAPHIC 333763
34 GRAPHIC g109855ex99_2p19g1.jpg GRAPHIC 433439
35 GRAPHIC g109855ex99_2p1g1.jpg GRAPHIC 267216
36 GRAPHIC g109855ex99_2p20g1.jpg GRAPHIC 256071
37 GRAPHIC g109855ex99_2p21g1.jpg GRAPHIC 280864
38 GRAPHIC g109855ex99_2p22g1.jpg GRAPHIC 238813
39 GRAPHIC g109855ex99_2p23g1.jpg GRAPHIC 325839
40 GRAPHIC g109855ex99_2p24g1.jpg GRAPHIC 240696
41 GRAPHIC g109855ex99_2p25g1.jpg GRAPHIC 412165
42 GRAPHIC g109855ex99_2p26g1.jpg GRAPHIC 366702
43 GRAPHIC g109855ex99_2p27g1.jpg GRAPHIC 297209
44 GRAPHIC g109855ex99_2p28g1.jpg GRAPHIC 62235
45 GRAPHIC g109855ex99_2p29g1.jpg GRAPHIC 266820
46 GRAPHIC g109855ex99_2p2g1.jpg GRAPHIC 475754
47 GRAPHIC g109855ex99_2p30g1.jpg GRAPHIC 193302
48 GRAPHIC g109855ex99_2p31g1.jpg GRAPHIC 314412
49 GRAPHIC g109855ex99_2p32g1.jpg GRAPHIC 376280
50 GRAPHIC g109855ex99_2p33g1.jpg GRAPHIC 264529
51 GRAPHIC g109855ex99_2p34g1.jpg GRAPHIC 274634
52 GRAPHIC g109855ex99_2p35g1.jpg GRAPHIC 283451
53 GRAPHIC g109855ex99_2p36g1.jpg GRAPHIC 320326
54 GRAPHIC g109855ex99_2p37g1.jpg GRAPHIC 281144
55 GRAPHIC g109855ex99_2p38g1.jpg GRAPHIC 398504
56 GRAPHIC g109855ex99_2p39g1.jpg GRAPHIC 258074
57 GRAPHIC g109855ex99_2p3g1.jpg GRAPHIC 379187
58 GRAPHIC g109855ex99_2p4g1.jpg GRAPHIC 237077
59 GRAPHIC g109855ex99_2p5g1.jpg GRAPHIC 248731
60 GRAPHIC g109855ex99_2p6g1.jpg GRAPHIC 371044
61 GRAPHIC g109855ex99_2p7g1.jpg GRAPHIC 329011
62 GRAPHIC g109855ex99_2p8g1.jpg GRAPHIC 361570
63 GRAPHIC g109855ex99_2p9g1.jpg GRAPHIC 270275
  Complete submission text file 0001193125-24-003964.txt   24276444

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dawn-20240108.xsd EX-101.SCH 2856
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dawn-20240108_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dawn-20240108_pre.xml EX-101.PRE 11265
65 EXTRACTED XBRL INSTANCE DOCUMENT d109855d8k_htm.xml XML 3368
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 24518491
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)